Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.

Source:http://linkedlifedata.com/resource/pubmed/id/8438342

Download in:

View as

General Info

PMID
8438342